Massive dilution overhang from this registration will likely pressure ONCO shares. Monitor for stockholder vote on authorized share increase, which would unlock full conversion of Series F Preferred Stock and enable further dilution. The pending Realbotix transaction adds binary event risk — if it closes, current shareholders face 75-90% dilution; if it fails, the company may pursue liquidation.
Executive Summary
Onconetix filed Amendment No. 1 to its S-1 registration statement to register the resale of up to 100,000,000 shares of common stock by Seven Knots LLC, the sole holder of Series F Preferred Stock. The shares represent 2,282% of current outstanding shares and are issuable upon conversion of Series F Preferred Stock issued in a July 2026 PIPE financing. The company has a going concern warning, minimal cash ($5.1M as of Aug 28, 2026), and a history of dilutive financings, making this filing a clear bearish signal of massive potential dilution.
Key Facts
- Registration covers resale of up to 100,000,000 shares of common stock by Seven Knots LLC, representing 2,282% of outstanding shares as of August 28, 2026.
- Shares are issuable upon conversion of 37,812 shares of Series F Preferred Stock issued in a July 2026 PIPE financing for an aggregate purchase price of $30,249,600 (satisfied by $30M commitment fee cancellation plus $249,600 cash).
- Initial conversion price is $0.9767 per share, with a floor price of $0.19534 that adjusts downward every six months; variable conversion pricing at 90-95% of VWAP applies after stockholder approval.
- Due to Nasdaq exchange cap and beneficial ownership limitations, only 789,426 shares can currently be issued; company will seek shareholder approval to increase authorized shares.
- Company has a going concern warning, cash of $5.1M as of August 28, 2026, accumulated deficit of $138.3M, and negative operating cash flow of $4.0M in H1 2026.
- Seven Knots LLC is deemed an underwriter for the resale; company will not receive any proceeds from this offering.
- Pending Realbotix share exchange transaction would result in a change of control with the seller owning 75-90% of fully diluted shares depending on net cash at closing.
Financial Impact
Potential dilution of 2,282% of current outstanding shares; registration covers 100M shares vs 4.38M outstanding. Series F Preferred Stock carries $30.25M stated value but was mostly satisfied by cancellation of a $30M commitment fee, so net cash infusion was only $249,600.
Risk Factors
- Extreme dilution from conversion of Series F Preferred Stock and other convertible securities (Series C, D, E preferred and warrants).
- Going concern risk — cash balance of $5.1M insufficient to fund operations for one year.
- Nasdaq delisting risk — stock price of $0.6120 below $1.00 minimum bid price requirement.
- Failure of Realbotix transaction could lead to dissolution and liquidation.
- Toxic financing structure with variable conversion prices that reset lower, encouraging aggressive selling by the investor.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001213900-26-095703 |
| Document: ea030384601ex23-1.htm | 0001213900-26-095703 |
| Document: 0001213900-26-095703-index-headers.html | 0001213900-26-095703 |
| Document: 0001213900-26-095703-index.html | 0001213900-26-095703 |
| Document: 0001213900-26-095703.txt | 0001213900-26-095703 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | DEFA14A / 8-K | $0.6374 $0.6549 | ▲ +2.75% | ▲ +2.64% | $0.7440 (+16.72%) |
Sep 14, 2026 18d ago | 8-K | $0.6374 $0.6549 | ▼ −2.75% | ▼ −2.64% | $0.7440 (−16.72%) |
Sep 14, 2026 18d ago | 425 | $0.6374 $0.6549 | ▼ −2.75% | ▼ −2.64% | $0.7440 (−16.72%) |
Sep 4, 2026 28d ago | EFFECT | $1.02 $0.6374 | ▲ +37.51% | ▲ +36.30% | $0.7440 (+27.06%) |
Sep 3, 2026 29d ago | 425 | $0.7390 $0.7564 | ▲ +2.35% | ▲ +3.50% | $0.7440 (+0.68%) |
Aug 31, 2026 4w ago | S-1/A | $0.6528 $0.8132 | ▼ −24.57% | ▼ −24.49% | $0.7440 (−13.97%) |
Aug 12, 2026 7w ago | S-1 | $0.8920 $0.7110 | ▲ +20.29% | ▲ +19.85% | $0.7440 (+16.59%) |
Jul 29, 2026 9w ago | 8-K | $0.7864 $0.9037 | ▼ −14.92% | ▼ −11.29% | $0.7440 (+5.39%) |
Jul 7, 2026 12w ago | 425 | $1.07 $0.8487 | ▼ −20.68% | ▼ −21.23% | $0.7440 (−30.47%) |
Jun 17, 2026 15w ago | EFFECT | $0.9949 $1.00 | ▼ −0.51% | ▼ −1.55% | $0.7440 (+25.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access